摘要
目的:分析2012年版《国家基本药物目录》中适宜儿童的药物,为制订我国《儿童基本药物目录》提供循证参考。方法:采用2012年版《国家基本药物目录》与2009年版《国家基本药物目录(基层部分)》、《世界卫生组织(WHO)儿童基本药物标准清单》比较方法,描述性分析3份目录在药物种类、药物剂型和药物规格上的异同。结果:2012年版《国家基本药物目录》基本覆盖了儿童常用药类别,但未包含《WHO儿童基本药物标准清单》中的血液制品、消毒剂和新生儿特殊用药。2012年版《国家基本药物目录》尚缺乏儿童专用药物以及对儿童用药物的年龄限制和说明。结论:2012年版《国家基本药物目录》考虑了儿童用药的需求,但不能根本解决儿童用药不足的问题,建议多部门联合,加大扶持力度,进一步完善儿童用药政策。
ABSTRACT Objective： To analyze the drugs suitable for children of the 2012 edition of National Essential Drug List so as to provide an evidence-based reference for the establishment of Essential Medicine List for Children. Meth- otis： A comparison was made among the 2012 edition of National Essential Medicine List and 2009 edition of National Essential Medicine List （Primary part） and WHO Model List of Essential Medicines for Children and a descriptive analysis was made of the similarity and difference of the three lists in the aspects of type of drugs, drug dosage form and drug specifications. Results： National Essential Medicine List of 2012 edition has basically covered the commonly used drugs for children but did not contain the blood products, disinfectants and the drugs specialized for neonates as mentioned in WHO Model List of Essential Medicines for Children. In addition, the medicines specialized for children and the instructions of age limit and the direction for use of the medicines for children are not included in it. Conclu- sion： The 2012 edition of National Essential Medicine List can basically meet the needs of children＇ s medication, but the problem of insufficient supply of the medicines for children still existed. It is suggested that joint efforts should be paid by departments concerned and more support be provided to further improve the policy for children＇s medication.
出处
《中国执业药师》
CAS
2013年第5期15-19,共5页
China Licensed Pharmacist
基金
科技部"重大新药创制"科技重大专项"十二五"实施计划(2011ZX09302-007-01)
药物政策与基本药物制度司2012年委托课题(2012年版基本药物目录儿童适宜品种
剂型
规格的标准化研究)
